GSK Investigational Site
Quilmes B1878GEG
3 studies enrolling now · 13 studies all time
What they study most
Arthritis, Rheumatoid, Asthma, Diabetes Mellitus, Type 2, Hypereosinophilic Syndrome, Lung Cancer, Non-Small Cell, Metastatic Cervical Cancer, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Neoplasms, Head and Neck, Neoplasms, Uterine Cervix, Pulmonary Disease, Chronic Obstructive
Studies at this site
- Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial — Recruiting now
- A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) — Recruiting now
- Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) — Recruiting now
- Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE) — Completed
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma — Running, not enrolling
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed
- GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
- Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) — Completed
- COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
- Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer — Completed
- Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
- Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery — Completed
- Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed